Enochian Biosciences, Inc.
ENOB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $1,874 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $691 | $0 |
| Total Curr. Assets | $0 | $0 | $2,565 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $1,423 | $0 |
| Goodwill | $0 | $0 | $11,640 | $0 |
| Intangibles | $0 | $0 | $40 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $42,633 | $0 |
| Total NC Assets | $0 | $0 | $55,735 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $0 | $58,301 | $0 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $5,297 | $0 |
| Short-Term Debt | $0 | $0 | $4,818 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $908 | $0 |
| Total Curr. Liab. | $0 | $0 | $11,023 | $0 |
| LT Debt | $0 | $0 | $776 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $776 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $969 | $0 |
| Total Liabilities | $0 | $0 | $11,799 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $6 | $0 |
| Retained Earnings | -$1 | -$0 | -$244,029 | -$0 |
| AOCI | $0 | -$0 | -$30 | -$0 |
| Other Equity | $0 | $0 | $290,555 | $0 |
| Total Equity | -$0 | $0 | $46,502 | $0 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $0 | $58,301 | $0 |
| Net Debt | $0 | $0 | $3,719 | -$0 |